Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its subsidiary RadQual has signed an Agreement with LEA for distribution of their ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce the following developments. International Isotopes recently signed a ...
International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and nine months ended September 30, ...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and six months ended June 30, 2020. ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces the highlights of the recent Board of Directors meeting and voting results on...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has hired Dr. James R. Miles, PharmD., ANP as its new...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2020....
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2019. The Company...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has received approval from the U.S. Food and Drug Administration...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three and nine months ended September 30, 2019....
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and six months ended June 30, 2019. ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three months ended March 31, 2019. Total revenue...
International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced it has executed a manufacturing and supply agreement with Progenics...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2018. The Company...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three and nine months ended September 30, 2018....
International Isotopes Inc. (OTCQB: INIS) (the "Company") in conjunction with the University Of Missouri Research Reactor (MURR), is pleased to...
International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced it has recently been awarded more than a dozen contracts for various types of ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three and six months ended June 30, 2018. Revenue...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the first quarter ended March 31, 2018. Revenue for the ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2017. The Company...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces financial results for the third quarter and nine months ended September 30, 2017. ...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") has announced that Dr. Robert W. Atcher, PhD, MBA, FSNMMI has accepted a position ...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announced that a group of buyers has acquired all the units of RadQual, LLC...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.